Cargando…
Isoprostanoids in Clinical and Experimental Neurological Disease Models
Isoprostanoids are a large family of compounds derived from non-enzymatic oxidation of polyunsaturated fatty acids (PUFAs). Unlike other oxidative stress biomarkers, they provide unique information on the precursor of the targeted PUFA. Although they were discovered about a quarter of century ago, t...
Autores principales: | Signorini, Cinzia, De Felice, Claudio, Galano, Jean-Marie, Oger, Camille, Leoncini, Silvia, Cortelazzo, Alessio, Ciccoli, Lucia, Durand, Thierry, Hayek, Joussef, Lee, Jetty Chung-Yung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071265/ https://www.ncbi.nlm.nih.gov/pubmed/29997375 http://dx.doi.org/10.3390/antiox7070088 |
Ejemplares similares
-
Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease
por: Signorini, Cinzia, et al.
Publicado: (2022) -
Circulating 4-F(4t)-Neuroprostane and 10-F(4t)-Neuroprostane Are Related to MECP2 Gene Mutation and Natural History in Rett Syndrome
por: Signorini, Cinzia, et al.
Publicado: (2021) -
Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder
por: Signorini, Cinzia, et al.
Publicado: (2013) -
Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs
por: Leoncini, Silvia, et al.
Publicado: (2015) -
Effects of ω-3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome
por: De Felice, Claudio, et al.
Publicado: (2013)